Antimicrobial and Anti-biofilm Activity of Thiourea Derivatives Incorporating a 2-Aminothiazole Scaffold
-
- Stefanska Joanna
- Department of Pharmaceutical Microbiology, Medical University
-
- Nowicka Grażyna
- Department of Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw
-
- Struga Marta
- Department of Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw
-
- Szulczyk Daniel
- Department of Medical Chemistry, Medical University
-
- Koziol Anna Eugenia
- Faculty of Chemistry, Maria Curie-Sklodowska University
-
- Augustynowicz-Kopec Ewa
- Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute
-
- Napiorkowska Agnieszka
- Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute
-
- Bielenica Anna
- Chair and Department of Biochemistry, Medical University of Warsaw
-
- Filipowski Wojciech
- Silesian University of Technology, Faculty of Automatic Control, Electronics and Computer Science, Institute of Electronics
-
- Filipowska Anna
- Silesian University of Technology, Faculty of Automatic Control, Electronics and Computer Science, Institute of Electronics Silesian University of Technology, Faculty of Biomedical Engineering, Department of Biosensors and Processing of Biomedical Signals
-
- Drzewiecka Aleksandra
- Institute of Physics, Polish Academy of Sciences
-
- Giliberti Gabriele
- Department of Biomedical Science, University of Cagliari
-
- Madeddu Silvia
- Department of Biomedical Science, University of Cagliari
-
- Boi Stefano
- Department of Biomedical Science, University of Cagliari
-
- Colla Paolo La
- Department of Biomedical Science, University of Cagliari
-
- Sanna Giuseppina
- Department of Biomedical Science, University of Cagliari
この論文をさがす
抄録
A series of new thiourea derivatives of 1,3-thiazole have been synthesized. All obtained compounds were tested in vitro against a number of microorganisms, including Gram-positive cocci, Gram-negative rods and Candida albicans. Compounds were also tested for their in vitro tuberculostatic activity against the Mycobacterium tuberculosis H37Rv strain, as well as two ‘wild’ strains isolated from tuberculosis patients. Compounds 3 and 9 showed significant inhibition against Gram-positive cocci (standard strains and hospital strain). The range of MIC values is 2–32 µg/mL. Products 3 and 9 effectively inhibited the biofilm formation of both methicillin-resistant and standard strains of S. epidermidis. The halogen atom, especially at the 3rd position of the phenyl group, is significantly important for this antimicrobial activity. Moreover, all obtained compounds resulted in cytotoxicity and antiviral activity on a large set of DNA and RNA viruses, including Human Immunodeficiency Virus type 1 (HIV-1) and other several important human pathogens. Compound 4 showed activity against HIV-1 and Coxsackievirus type B5. Seven compounds resulted in cytotoxicity against MT-4 cells (CC50<10 µM).
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 63 (3), 225-236, 2015
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204177655936
-
- NII論文ID
- 130004803782
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 026193113
-
- PubMed
- 25757494
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可